Literature DB >> 28579429

The EGF receptor inhibits the signaling of dopamine D3 receptor through the phosphorylation of GRK2 on tyrosine residues.

NingNing Sun1, Xiaowei Zhang1, Xiaohan Zhang1, Kyeong-Man Kim2.   

Abstract

Receptor transactivation or crosstalk are terms referring to instances in which the signaling of a given receptor is regulated by a different class of receptor. The epidermal growth factor (EGF) and the dopaminergic systems in the brain are closely related to schizophrenia with respect to both etiology and treatment. Thus, we investigated the functional interactions between the EGF receptor (EGFR), which belongs to the receptor tyrosine kinase family, and the dopamine D2-like receptors (D2R, D3R, and D4R), which are members of the G protein-coupled receptor (GPCR) family. Among D2-like receptors, the signaling of D3R was selectively inhibited by EGFR stimulation. Moreover loss-of-function assays showed that tyrosine-phosphorylated GRK2 mediates this inhibition by acting on the second intracellular loop of D3R. Considering that both EGFR and D3R are closely related to schizophrenia, this study could provide new molecular insight into the etiology of the disorder.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dopamine D(3) receptor; EGFR; GRK2; Protein kinase C; β-Arrestin

Mesh:

Substances:

Year:  2017        PMID: 28579429     DOI: 10.1016/j.bbrc.2017.05.183

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

Review 1.  Extramembranous Regions in G Protein-Coupled Receptors: Cinderella in Receptor Biology?

Authors:  Sreetama Pal; Amitabha Chattopadhyay
Journal:  J Membr Biol       Date:  2019-08-30       Impact factor: 1.843

Review 2.  G Protein-Coupled Receptor Kinase 2 (GRK2) as a Potential Therapeutic Target in Cardiovascular and Metabolic Diseases.

Authors:  Cristina Murga; Alba C Arcones; Marta Cruces-Sande; Ana M Briones; Mercedes Salaices; Federico Mayor
Journal:  Front Pharmacol       Date:  2019-02-19       Impact factor: 5.810

Review 3.  G protein-coupled receptor kinase 2 (GRK2) as a multifunctional signaling hub.

Authors:  Petronila Penela; Catalina Ribas; Francisco Sánchez-Madrid; Federico Mayor
Journal:  Cell Mol Life Sci       Date:  2019-08-20       Impact factor: 9.261

4.  Modulation of CXCR4-Mediated Gi1 Activation by EGF Receptor and GRK2.

Authors:  Maria Neves; Cristina Perpiñá-Viciano; Petronila Penela; Carsten Hoffmann; Federico Mayor
Journal:  ACS Pharmacol Transl Sci       Date:  2020-04-27

5.  Decreased Serum EGF in First-episode and Chronic Schizophrenia Patients: Negative Correlation with Psychopathology.

Authors:  Xiaobin Zhang; Wenhuan Xiao; KuanYu Chen; Yaqin Zhao; Fei Ye; Xiaowei Tang; Xiangdong Du
Journal:  Sci Rep       Date:  2020-04-16       Impact factor: 4.379

6.  Serum Epidermal Growth Factor is Low in Schizophrenia and Not Affected by Antipsychotics Alone or Combined With Electroconvulsive Therapy.

Authors:  Xiaobin Zhang; Wenhuan Xiao; KuanYu Chen; Yaqin Zhao; Fei Ye; Xiaowei Tang; Xiangdong Du
Journal:  Front Psychiatry       Date:  2020-03-03       Impact factor: 4.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.